|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM345052129 |
003 |
DE-627 |
005 |
20231226024206.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2022 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1002/adma.202206008
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1150.xml
|
035 |
|
|
|a (DE-627)NLM345052129
|
035 |
|
|
|a (NLM)35986672
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Ferdosi, Shadi
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Enhanced Competition at the Nano-Bio Interface Enables Comprehensive Characterization of Protein Corona Dynamics and Deep Coverage of Proteomes
|
264 |
|
1 |
|c 2022
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 07.11.2022
|
500 |
|
|
|a Date Revised 07.11.2022
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a © 2022 The Authors. Advanced Materials published by Wiley-VCH GmbH.
|
520 |
|
|
|a Introducing engineered nanoparticles (NPs) into a biofluid such as blood plasma leads to the formation of a selective and reproducible protein corona at the particle-protein interface, driven by the relationship between protein-NP affinity and protein abundance. This enables scalable systems that leverage protein-nano interactions to overcome current limitations of deep plasma proteomics in large cohorts. Here the importance of the protein to NP-surface ratio (P/NP) is demonstrated and protein corona formation dynamics are modeled, which determine the competition between proteins for binding. Tuning the P/NP ratio significantly modulates the protein corona composition, enhancing depth and precision of a fully automated NP-based deep proteomic workflow (Proteograph). By increasing the binding competition on engineered NPs, 1.2-1.7× more proteins with 1% false discovery rate are identified on the surface of each NP, and up to 3× more proteins compared to a standard plasma proteomics workflow. Moreover, the data suggest P/NP plays a significant role in determining the in vivo fate of nanomaterials in biomedical applications. Together, the study showcases the importance of P/NP as a key design element for biomaterials and nanomedicine in vivo and as a powerful tuning strategy for accurate, large-scale NP-based deep proteomic studies
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Vroman effect
|
650 |
|
4 |
|a machine learning
|
650 |
|
4 |
|a nano-bio interactions
|
650 |
|
4 |
|a nanoparticles
|
650 |
|
4 |
|a protein corona
|
650 |
|
4 |
|a proteomics
|
650 |
|
7 |
|a Protein Corona
|2 NLM
|
650 |
|
7 |
|a Proteome
|2 NLM
|
700 |
1 |
|
|a Stukalov, Alexey
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hasan, Moaraj
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tangeysh, Behzad
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Brown, Tristan R
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Tianyu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Elgierari, Eltaher M
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhao, Xiaoyan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Huang, Yingxiang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Alavi, Amir
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lee-McMullen, Brittany
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chu, Jessica
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Figa, Mike
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tao, Wei
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Jian
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Goldberg, Martin
|e verfasserin
|4 aut
|
700 |
1 |
|
|a O'Brien, Evan S
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Xia, Hongwei
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Stolarczyk, Craig
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Weissleder, Ralph
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Farias, Vivek
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Batzoglou, Serafim
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Siddiqui, Asim
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Farokhzad, Omid C
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hornburg, Daniel
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 34(2022), 44 vom: 01. Nov., Seite e2206008
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
773 |
1 |
8 |
|g volume:34
|g year:2022
|g number:44
|g day:01
|g month:11
|g pages:e2206008
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202206008
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 34
|j 2022
|e 44
|b 01
|c 11
|h e2206008
|